1[1]Dudkiewicz J,Waksmanski B,Cieslak-stec M,et al.Analysis of clinical usefulness of the cytologic smear results for pregnant woman using the Bathesda system.Ginekol Pol 2002;73:314-9.
2[2]Chan PK,Chang AR,Tam WH,et al.Prevalence and genotype distribution of cervical human papillomavirus infection:comparison between pregnant women and non-pregnant controls.J Med Virol 2002; 67:583-8.
4[4]Caputo S,Salvi M,Ciardo A.Prognosis and treatment of cervix uteri carcinoma in pregnancy.Clin Ter 2002;152:197-200.
5[5]Murta EF,de Andrade FC,Adad S J,et al.Low-grade cervical squa mous intraepithelial lesion during pregnancy:conservative antepartum management.Eur J Gynaecol Oncol 2004;25:600-2.
6[6]Kowalska-Koprek U,Pajszczyk-Kieszkiewicz T,KarowiczBiliniska A.Cervical dysplasia and cervical carcinoma in pregnant women.Ginekol Pol 2005;76:203-8.
7[7]Cristoforoni DM,Gerbaldo DL,Philipson J,et al.Management of the abnormal papanicolaou smear during pregnancy:lessons for quality improvement.Obstet Gynecol Surg 2000;55:149-50.
8[8]Paraskevaidis E,Koliopoulos G,Kalantaridou S,et al.Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum.Eur J Obstet Gynecol Reprod Biol 2002; 104:67-9.
9[9]Wright TC Jr,Cox JT,Massad LS,et al.2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.JAMA 2002:287:2120-9.
10Anttila A, Pukkala E, Soderman B, et al. Effect of organized screening on cervical cancer incidence and mortality in Finland,1963-1995:Recent increase in cervical cancer incidence [J]. Int J Cancer, 1999, 83(1):59～65
